FULC — Fulcrum Therapeutics Share News
0.000.00%
Last trade - 00:00- $253.21m
- -$80.11m
U.S. STOCKS ON THE MOVE-Five Below, Boeing, Instacart
Buzz Us Stocks On The Move: Tesla, Warner Bros Discovery, Netflix
Fulcrum Therapeutics jumps after trial data of blood disorder drug
U.S. STOCKS ON THE MOVE-Micron, NextEra Energy, Ocular Therapeutix
Fulcrum Therapeutics rises after trial data of blood disorder drug
Brief: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Alphabet, Boeing, KLA
Fulcrum Therapeutics' Q3 net loss narrows
Brief: Fulcrum Therapeutics Q3 Basic EPS USD -0.31
U.S. RESEARCH ROUNDUP- AGCO, Caterpillar, United Rentals
Brief: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fulcrum Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulcrum Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule
Fulcrum Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Fulcrum Therapeutics Q1 Basic EPS USD -0.28
Fulcrum Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Fulcrum Therapeutics Inc Myokardia Terminates Collaboration And License Agreement With Co
Fulcrum Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary